Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 

       2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Omeprazole Sodium capsules

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Omeprazole Sodium Manufacturers in India Suppliers Omeprazole Sodium Exporters Distributors Omeprazole Sodium api active pharmaceuticals ingredients Omeprazole Sodium manufacturers Side Effects bulk drugs raw material Omeprazole Sodium companies Side Effects Importers Omeprazole Sodium Omeprazole Sodium Exporters Omeprazole Sodium exporters FDA Omeprazole Sodium DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Omeprazole Sodium manufacturing pharmaceutical drugs pharmaceutical intermediates Omeprazole Sodium pharmaceutical chemicals pharmaceutical raw materials Omeprazole Sodium active pharmaceutical ingredients Omeprazole Sodium committee active pharmaceutical ingredients manufacturer Omeprazole Sodium Active Pharmaceutical Ingredients manufacturer Omeprazole Sodium exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Omeprazole Sodium, Omeprazole Sodium manufacturer India, Omeprazole Sodium product, Omeprazole Sodium products, Api preparation, Certificate of Analysis API manufacturer product, Omeprazole Sodium anti ulcer product, Certificate of Origin COA Omeprazole Sodium COS Omeprazole Sodium, pharmaceutical generic, pharmaceutical drug, medical, Omeprazole Sodium pharma healthcare, pharma patents, contract MSDS manufacturing Trader Omeprazole Sodium pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Omeprazole Sodium expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Omeprazole Sodium DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Omeprazole Sodium ingredients, api, HIV Omeprazole Sodium, tablets, capsules, syrup & protein Omeprazole Sodium powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Omeprazole Sodium gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Omeprazole Sodium WHO, UKMHRA Approval

   Pharmaceuticals API List >>
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us

acid media,


Omeprazole Sodium Omeprazole Sodium

Omeprazole Sodium Omeprazole Sodium





HOME >> Pharmaceuticals API List 2 >> Omeprazole Sodium

Omeprazole Sodium CAS No. 95510-70-6

Omeprazole Sodium pdf api

CAS number 95510-70-6

Omeprazole Sodium  formula :-C17H19N3O3S,




Omeprazole Sodium

Omeprazole Sodium

omeprazole/sodium bicarbonateis a combination of omeprazole, a proton-pump inhibitor, and sodium bicarbonate, an antacid. Omeprazole is a substituted benzimidazole, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole, a racemic mixture of two enantiomers that inhibits gastric acid secretion. Its empirical formula is C17H19N3O3S, with a molecular weight of 345.42.

Omeprazole is a white to off-white crystalline powder which melts with decomposition at about 155C. It is a weak base, freely soluble in ethanol and methanol, and slightly soluble in acetone and isopropanol and very slightly soluble in water. The stability of omeprazole is a function of pH; it is rapidly degraded in acid media, but has acceptable stability under alkaline conditions.

omeprazole  is supplied as immediate-release capsules and unit-dose packets as powder for oral suspension. Each capsule contains either 40 mg or 20 mg of omeprazole and 1100 mg of sodium bicarbonate with the following excipients: croscarmellose sodium and sodium stearyl fumarate. Packets of powder for oral suspension contain either 40 mg or 20 mg of omeprazole and 1680 mg of sodium bicarbonate with the following excipients: xylitol, sucrose, sucralose, xanthan gum, and flavorings.

Side effects
Some of the most frequent side effects of omeprazole (experienced by over 1% of those taking the drug) are headache, diarrhea, abdominal pain, nausea, dizziness, trouble awakening and sleep deprivation, although in clinical trials the incidence of these effects with omeprazole was mostly comparable to that found with placebo.

Proton pump inhibitors may be associated with a greater risk of hip fractures, and clostridium difficile-associated diarrhea Patients are frequently administered the drugs in intensive care as a protective measure against ulcers, but this use is also associated with a 30% increase in occurrence of pneumonia.

Other side effects may include bone rebuild interference and B12 vitamin reduction.

Information Associated with Product:
Omeprazole Sodium CAS number 95510-70-6
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj pharmaceuticals API Logo

Omeprazole Sodium

More Api at Taj Pharmaceuticals Ltd.





Levo Cetirizine



Losartan Potassium

Metoprolol Succinate

Montelukast Sodium

Moxifloxacin HCl







Omeprazole Sodium





Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap


taj group logo
2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.